Topical cenegermin promotes corneal healing in patients with neurotrophic keratopathy
- Posted on: Jan 28 2020
- Leave a response
This study assessed the efficacy of recombinant human nerve growth factor therapy cenegermin (Oxervate) for neurotrophic keratopathy.
Source: AAO
Posted in: Uncategorized
